• Contact
  • EPAD Academy
Top Bar Menu
TwitterFacebookYouTube
Search...
EPADEPAD
EPAD
European Prevention of Alzheimer's Dementia Consortium
  • Home
  • About
    • Welcome to EPAD
    • Project Objectives
    • Project Structure
    • EPAD Partners
    • Coordination & Management
    • EPAD Q&A
  • Our research
    • Participation in EPAD
      • Participation in EPAD Cohort
      • EPAD Study Visits
      • Trial Locations
      • Participation FAQs
    • The Participant’s Experience
      • The Research Participant Panel
      • EPAD Stories
    • The EPAD platform
      • The EPAD Platform
      • EPAD Benefits
      • Clinical Candidate Selection
      • EPAD FAQs
      • Research Resources
  • Open Access Data
    • Overview
    • Access
    • Data
    • MRI Images
  • Sample Access
  • News & Publications
    • Latest News
    • Newsletters
    • Publications
    • Videos
Menu back  

Loading Events

« All Events

  • This event has passed.

WORLD ALZHEIMER’S DAY

September 21, 2018

  • « 41st Annual Meeting of the European Society of Neuroradiology
  • 10th IMI Scientific Symposium »

World Alzheimer’s Day, September 21st of each year, is a day on which Alzheimer’s organisations around the world concentrate their efforts on raising awareness about Alzheimer’s and dementia. Alzheimer’s disease is the most common form of dementia, a group of disorders that impairs mental functioning. 

The theme for this year’s World Alzheimer’s Month campaign is Every 3 seconds. ADI is encouraging people all around the world to understand the importance of recognising dementia as a disease and challenging the stigma that surrounds the condition.

Every 3 seconds, someone in the world develops dementia. The number of people living with dementia around the world is expected to almost double every 20 years, reaching 152 million by 2050.  

 

As every year on World Alzheimer’s Day, many Alzheimer associations and other stakeholders around the world will organise advocacy and information provision events to show the global impact of dementia and promote dementia awareness. September is a busy month for our EPAD partners and TDCs, with a number of meetings and events taking place to join the World Alzheimer’s Month campaign. This year, we are glad to report some activities planned by our Epadistas: 

CHUT (Toulouse, France)

Together with the French Alzheimer association « France Alzheimer » of its department, the CHUT will organise an event on World Alzheimer’s Day entitled «Changeons de regard pour comprendre et agir ». Dr Pierre Jean Ousset will give a presentation on Alzheimer’s disease. The programme could be downloaded here. 

CHRU (Lille, France)

Several events will be organised on World Alzheimer’s Day in Lille including a meeting to celebrate the 25 years of the Bailleul advanced consultation. This meeting will be organised for the general public at the “centre médical des monts de flandres” involving many CHRU’s consultants. 

IRCCS Fatebenefratelli (Brescia, Italy)

As every year for the World Alzheimer’s Day, the well-known Millennium gym in Brescia – located in front of the Brescia’s Institute “IRCCS Centro San Giovanni di Dio Fatebenefratelli” – organises an event called “Move for Alzheimer / Muoviamoci per l’Alzheimer” to raise funds and support research for Alzheimer’s disease. This year, the event lastes one week (September 13-21) and the program consistes of a series of sporting events aimed at the entire population, such as pole dance, soccer and yoga. During this occasion, some researchers of the IRCCS Fatebenefratelli will take the opportunity to explain the research activity of the Institute at dedicated stands. The programme of the event could be downloaded here. 

On September 21, an informational meeting aimed at patients and their relatives will also be organised at the IRCCS Fatebenefratelli to increase the awareness on Alzheimer’s disease and patient’s care. The Chief Medical Officer, the director-General, a clinician and a qualified trainer of the institute will be speakers at this event.

Karolinska Institutet (Stockholm, Sweden)

On Sept 21st Karolinska Institutet and Theme Aging, Karolinska University Hospital, will recognize the seventh World Alzheimer’s Day. They will be given the opportunity to attend lectures from frontiers, among others Prof Miia Kivipelto and her team, within the field of Alzheimer prevention, diagnostics, and treatment. In a parallel event, sponsored by the Swedish Alzheimer Foundation, Associate Prof Alina Solomon will give a lecture regarding how one can prevent dementia and multi-domain interventions. After that, a joint visit to their new Memory Clinic at Karolinska University Hospital Solna will be organised. During the evening of the same day Prof Kivipelto will travel to Helsinki, Finland to participate in the gala event of Alzheimer Association Finland, where she will receive the first time ever gold medal awarded for her contributions for dementia prevention and patient care. They look forward to listen to these frontier EPADistas during this special day. 

Paris Nord GH de Lariboisiere (Paris, France)

For the World Alzheimer’s Day, France Alzheimer organises an event from 21st September to 23rd September in Paris. In the space of these three days, several topics will be presented and discussed including adapted physical activities, prevention, early diagnosis, treatments, scientific research, nutrition and carers in professional activity. 33 hours of workshops and 17 presentations are planned on the occasion of the 6th edition of the “Alzheimer Village”. The program that could be downloaded here promises to be rich and intense. We are glad to see that thee members of the Paris Nord GH de Lariboisiere are intervening for this event. On 22nd September, Dr Julien Dumurgier and Aurelie Meauzoone will give a presentation about the early diagosis. Pr Claire Paquet will report about the frontotemporal degenerations and the Lewy body disease.

UNIGE (Geneva, Switzerland)

The Geneva’s team takes this unique opportunity to raise public’s awareness towards the cognitive impairments and Alzheimer’s disease. They organise an event at the Geneva’s hospital with outstanding moderators and speakers from the hospital. The programme could be downloaded here. The team is glad to have on board the Head of the Health department at the level of the canton (local state). Their new “Centre de la mémoire” officially launched last February will also be presented including its mission, objectives and future enhancements.  

 

 

 

 

  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live

Details

Date:
September 21, 2018
  • « 41st Annual Meeting of the European Society of Neuroradiology
  • 10th IMI Scientific Symposium »
Share this page
FacebookTwitterLinkedInGoogle+
Latest News
  • Hormone Replacement Therapy could ward off Alzheimer’s among at-risk women
    2023-01-16
  • Associations between Mediterranean diet and cognition in the pan-European EPAD LCS
    2022-12-09
  • Bruno Steinkraus
    Interview with Dr. Bruno Steinkraus, Chief Scientific Officer at Hummingbird Diagnostics GmbH
    2022-11-25
  • New paper defining and discussing the substantial assets of the EPAD project is out!
    2022-11-23
  • New paper using the EPAD data for an analysis of sleep quality and efficiency
    2022-11-03
View the EPAD Brochure
thumbnail of EPAD brochure
Speak to the EPAD team
thumbnail of speech bubbles
Twitter
Twitter
EPAD
EPAD
@IMI_EPAD

"There is a growing consensus that individual research results that are potentially relevant should be reported to research participants” & “Our work was positively received by the EPAD partners, and formed the basis for the set-up & the conduct of the study,” said Eline Bunnik

reply retweet favorite
10:32 am · 2023-01-31
Twitter
EPAD
EPAD
@IMI_EPAD

Have a look on the @IHIEurope newsletter including a spotlight on IMI results from projects on diabetes @HypoResolve and #Alzheimer’s disease @IMI_EPAD @IMI_AMYPAD ⬇️ Read it: bit.ly/3jeaxdM twitter.com/IHIEurope/stat…

reply retweet favorite
10:30 am · 2023-01-31
Twitter
EPAD
EPAD
@IMI_EPAD

17 centres have contributed to the @IMI_AMYPAD Prognostic Study across 11 Parent Cohorts including @IMI_EPAD. Have a look on the latest AMYPAD paper published in @FrontNeurol ⬇️ twitter.com/IMI_AMYPAD/sta…

reply retweet favorite
8:19 am · 2023-01-30
Twitter
EPAD
EPAD
@IMI_EPAD

All data sets from the @IMI_EPAD Longitudinal Cohort Study are available in the @AlzData #ADWorkbench and we're pleased to see that more and more people are using the platform to share & discover #data to accelerate discoveries and innovations in the #Alzheimer's disease field⤵️ twitter.com/AlzData/status…

reply retweet favorite
8:41 am · 2023-01-25
Twitter
EPAD
EPAD
@IMI_EPAD

The Edinburgh Dementia Prevention Summer School 2023 will focus on the latest evidence for #dementia #prevention and promoting good #brainhealth ➡️5-day interactive online course ➡️For clinicians, nurses, health professionals, researchers ➡️Register here edin.ac/3iJNJST twitter.com/WTCRF_Educatio…

reply retweet favorite
1:38 pm · 2023-01-18
Workstream Progress
Workstream 120%
Workstream 232%
Workstream 310%
Workstream 446%
Contact us

Submitclear

Recent Posts
  • Hormone Replacement Therapy could ward off Alzheimer’s among at-risk women
  • Associations between Mediterranean diet and cognition in the pan-European EPAD LCS
  • Interview with Dr. Bruno Steinkraus, Chief Scientific Officer at Hummingbird Diagnostics GmbH
  • New paper defining and discussing the substantial assets of the EPAD project is out!
  • New paper using the EPAD data for an analysis of sleep quality and efficiency
Recent Comments
  • The EPAD genomic data is now available on the Alzheimer’s Disease Workbench on The EPAD genomic data is now available on the Alzheimer’s Disease Workbench
  • ADDI celebrates one year of achievements – Neuronet on ADDI celebrates one year of achievements
  • EPAD dataset is now available on the Alzheimer’s Disease Workbench on The final EPAD dataset is now available on the Alzheimer’s Disease Workbench
  • The final EPAD dataset is now available to the entire research community on The final EPAD dataset is now available to the entire research community
  • The ERC has awarded an ERC grant to identify age-related human blood factors as a therapeutic target for Alzheimer’s disease – Neuronet on New ERC starting grant to identify age-related human blood factors as a therapeutic target for Alzheimer’s disease
Archives
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • January 2022
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • June 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • June 2015
  • May 2015
  • April 2015
Categories
  • EPAD Academy
  • News
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Copyright © 2015-2021 EPAD | Created by CMAST and Aridhia
  • Acronyms
  • Legal Notice
  • Privacy Policy
Bottom Menu

efpia-logo EU imi logo

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD grant agreement nº 115736

This website uses cookies to improve your experience. Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT